ABUS Stock Summary and Trading Ideas (Arbutus Biopharma | NASDAQ:ABUS)

Arbutus Biopharma Corp is a clinical-stage biopharmaceutical company focused on infectious diseases. The company is leveraging its extensive virology expertise to identify and develop novel therapeutics with distinct mechanisms of action, which can be combined to provide a functional cure for patients with chronic hepatitis B virus (cHBV). Its pipeline of internally developed, proprietary compounds includes an RNAi therapeutic, imdusiran (AB-729), and an oral PD-L1 inhibitor, AB-101. In addition, the company is also focused on maximizing the opportunity for its in-house developed Lipid Nanoparticle (LNP) delivery technology.

What symbol and exchange does Arbutus Biopharma shares trade?

Arbutus Biopharma trades on the NASDAQ stock market under the symbol ABUS.

What is Arbutus Biopharma stock price doing today?

As of January 23, 2026, ABUS stock price declined to $4.06 with 1,078,905 million shares trading.

What is Arbutus Biopharma's Beta?

ABUS has a beta of 0.42, meaning it tends to be less sensitive to market movements. ABUS has a correlation of 0.04 to the broad based SPY ETF.

How much is Arbutus Biopharma worth?

ABUS has a market cap of $780.84 million. This is considered a Small Cap stock.

How much money does Arbutus Biopharma make?

Last quarter Arbutus Biopharma reported $529,000 in Revenue and -$.04 earnings per share. This fell short of revenue expectation by $-781,250 and met earnings estimates .

What is the highest and lowest price Arbutus Biopharma traded in the last 3 year period?

In the last 3 years, ABUS traded as high as $5.10 and as low as $1.69.

What are the top ETFs holding Arbutus Biopharma?

The top ETF exchange traded funds that ABUS belongs to (by Net Assets): VTI, IWM, XBI, VXF, IWO.

Is Arbutus Biopharma (ABUS) a good investment?

ABUS has outperformed the market in the last year with a return of +21.6%, while the SPY ETF gained +14.2%. However, in the most recent history, ABUS shares have underperformed the stock market with its stock returning -5.1% in the last 3 month period and -12.1% for the last 2 week period, while SPY has returned +2.9% and -0.7%, respectively.

What are the support and resistance levels for Arbutus Biopharma (ABUS)?

ABUS support price is $4.02 and resistance is $4.31 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ABUS shares will trade within this expected range on the day.